Abstract:Lipid metabolism deregulation constitutes the pathogenic basis for the development of atherosclerosis and justifies a high incidence of cardiovascular-related morbidity and mortality. Some data suggest that dyslipidemia may be associated with sleep-disordered breathing, mainly obstructive sleep apnea (OSA), due to alterations in fundamental biochemical processes, such as intermittent hypoxia (IH). The aim of this systematic review was to identify and critically evaluate the current evidence supporting the existence of a possible relationship between OSA and alterations in lipid metabolism. Much evidence shows that, during the fasting state, OSA and IH increase lipid delivery from the adipose tissue to the liver through an up-regulation of the sterol regulatory element-binding protein-1 and stearoyl-CoA desaturase-1, increasing the synthesis of cholesterol esters and triglycerides. In the postprandial state, lipoprotein clearance is delayed due to lower lipoprotein lipase activity, probably secondary to IH-up-regulation of angiopoietin-like protein 4 and decreased activity of the peroxisome proliferator-activated receptor alpha. Moreover, oxidative stress can generate dysfunctional oxidized lipids and reduce the capacity of high-density lipoproteins (HDL) to prevent low-density lipoprotein (LDL) oxidation. In the clinical field, several observational studies and a meta-regression analysis support the existence of a link between OSA and dyslipidemia. Although there is evidence of improved lipid profile after apnea-hypopnea suppression with continuous positive airway pressure (CPAP), the majority of the data come from observational studies. In contrast, randomized controlled trials evaluating the effects of CPAP on lipid metabolism present inconclusive results and two meta-analyses provide contradictory evidence.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between obstructive sleep apnea (OSA) and lipid metabolism disorders. Specifically, the author aims to identify and critically evaluate the current evidence supporting the possible link between OSA and abnormal lipid metabolism. This includes a systematic review from animal models to clinical evidence, with a focus on how intermittent hypoxia (IH) affects the key mechanisms of lipid metabolism and how these mechanisms are manifested in clinical studies, especially the impact of continuous positive airway pressure (CPAP) treatment on the lipid profile. ### Main issues: 1. **Relationship between OSA and lipid metabolism disorders**: - The author explores whether OSA can lead to lipid metabolism disorders and the specific mechanisms of such disorders. - Through animal models and clinical evidence, the author analyzes how OSA affects lipid metabolism through intermittent hypoxia (IH). 2. **Key mechanisms of lipid metabolism**: - **Lipid metabolism in the fasting state**: OSA and IH increase the synthesis of cholesterol esters and triglycerides by up - regulating sterol - regulatory element - binding protein - 1 (SREBP - 1) and stearoyl - CoA desaturase - 1 (SCD - 1), increasing the transport of lipids from adipose tissue to the liver. - **Lipid metabolism in the post - prandial state**: Due to the decreased activity of low - density lipoprotein lipase (LpL), lipoprotein clearance is delayed, which may be due to IH up - regulating angiopoietin - like protein 4 (Angptl4) and decreased activity of peroxisome proliferator - activated receptor α (PPAR - α). - **Oxidative stress**: Oxidative stress can generate dysfunctional oxidized lipids and reduce the ability of high - density lipoprotein (HDL) to prevent the oxidation of low - density lipoprotein (LDL). 3. **Clinical evidence**: - Multiple observational studies and meta - regression analyses support the association between OSA and lipid metabolism disorders. - Although there is evidence that CPAP treatment can improve the lipid profile of OSA patients, most of the data are from observational studies. The results of randomized controlled trials (RCTs) are inconsistent, and two meta - analyses provide contradictory evidence. ### Conclusion: Through a systematic review of the existing literature, the paper reveals the complex relationship between OSA and lipid metabolism disorders and emphasizes the crucial role of intermittent hypoxia in this process. However, although there is some evidence to support the improvement of the lipid profile by CPAP treatment, its exact effect still needs further research to be verified.

Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence

Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism

Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea

Metabolic consequences of sleep-disordered breathing

Effect of Continuous Positive Airway Pressure on Lipid Profiles in Obstructive Sleep Apnea: A Meta-Analysis

Chronic Intermittent Hypoxia-Induced Dysmetabolism Is Associated with Hepatic Oxidative Stress, Mitochondrial Dysfunction and Inflammation

Investigating the Relationship between Obstructive Sleep Apnoea, Inflammation and Cardio-Metabolic Diseases

Effect of Continuous Positive Airway Pressure on Lipid Profile in Patients with Obstructive Sleep Apnea Syndrome: a Meta-Analysis of Randomized Controlled Trials.

Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment

Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments

Gut Microbiota and Derived Metabolites Mediate Obstructive Sleep Apnea Induced Atherosclerosis

Predictors and markers of the cardiovascular impact of obstructive sleep apnoea

Association of dyslipidemia and hypoxemia in patients with obstructive sleep apnea hypopnea syndrome: a cross-sectional study

Obstructive sleep apnea: implications for cardiac and vascular disease

Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge.

Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption

The relationship between periodic limb movement during sleep and dyslipidaemia in patients with obstructive sleep apnea

Gender Differences in the Context of Obstructive Sleep Apnea and Metabolic Diseases

Obstructive sleep apnea syndrome attenuated high-density lipoprotein function

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea

Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review